Candida albicans biofilm development, modeling a host-pathogen interaction

Current Opinion in Microbiology

Volumn 9, Issue 4, 2006, Pages 340-345

  Nett, Jeniel ^a   Andes, David ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; DEVICE INFECTION; EXTRACELLULAR MATRIX; FUNGUS HYPHAE; HEART VALVE PROSTHESIS; HOST PATHOGEN INTERACTION; HUMAN; INTRAVENOUS CATHETER; MEDICAL INSTRUMENTATION; NONHUMAN; PHENOTYPE; REVIEW; YEAST;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; EQUIPMENT AND SUPPLIES; HUMANS; MODELS, BIOLOGICAL;

ANIMALIA; CANDIDA ALBICANS;

EID: 33746300488     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2006.06.007     Document Type: Review

References (56)

1. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W., Walsh T.J., and Edwards J.E. Guidelines for treatment of candidiasis. Clin Infect Dis 38 (2004) 161-189. The authors describe the epidemiology, clinical impact and management of Candida infections, including those associated with medical devices.
2. Kojic E.M., and Darouiche R.O. Candida infections of medical devices. Clin Microbiol Rev 17 (2004) 255-267. The authors provide a detailed review the impact and epidemiology of Candida device-infections.
3. Douglas L.J. Medical importance of biofilms in Candida infections. Rev Iberoam Micol 19 (2002) 139-143
4. Ramage G., Saville S.P., Thomas D.P., and Lopez-Ribot J.L. Candida biofilms: an update. Eukaryot Cell 4 (2005) 633-638. The authors provide an excellent up to date review of Candida biofilm biology.
5. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol 11 (2003) 30-36
6. Kumamoto C.A., and Vinces M.D. Alternative Candida albicans lifestyles: growth on surfaces. Annu Rev Microbiol 59 (2005) 113-133. This is an excellent review of Candida response to surface contact to tissue and devices.
7. Donlan R.M. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33 (2001) 1387-1392
8. Byers J.D., and Ratner B.D. Bioinspired implant materials befuddle bacteria. ASM News 70 (2004) 232-237. The authors review how a wide variety of host and device properties impact biofilm formation.
9. Ramage G., Vandewalle K., Wickes B.L., and Lopez-Ribot J.L. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18 (2001) 163-170
10. Hawser S.P., Baillie G.S., and Douglas L.J. Production of extracellular matrix by Candida albicans biofilms. J Med Microbiol 47 (1998) 253-256
11. Kuhn D.M., and Ghannoum M.A. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 5 (2004) 186-197
12. Baillie G.S., and Douglas L.J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46 (2000) 397-403
13. Mukherjee P.K., Chandra J., Kuhn D.M., and Ghannoum M.A. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71 (2003) 4333-4340
14. Ramage G., VandeWalle K., Bachmann S.P., Wickes B.L., and Lopez-Ribot J.L. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46 (2002) 3634-3636
15. Ramage G., Bachmann S., Patterson T.F., Wickes B.L., and Lopez-Ribot J.L. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49 (2002) 973-980
16. Ramage G., Vande Walle K., Wickes B.L., and Lopez-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45 (2001) 2475-2479
17. Al-Fattani M.A., and Douglas L.J. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 48 (2004) 3291-3297
18. Ramage G., Saville S.P., Wickes B.L., and Lopez-Ribot J.L. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 68 (2002) 5459-5463
19. Alem M.A., and Douglas L.J. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54 (2005) 1001-1005
20. Andes D., Nett J., Oschel P., Albrecht R., Marchillo K., and Pitula A. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72 (2004) 6023-6031. The authors describe the use of a rodent vascular catheter biofilm model for examination of architectural development, antifungal drug efficacy and gene expression.
21. Chandra J., Kuhn D.M., Mukherjee P.K., Hoyer L.L., McCormick T., and Ghannoum M.A. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183 (2001) 5385-5394
22. Richard M.L., Nobile C.J., Bruno V.M., and Mitchell A.P. Candida albicans biofilm-defective mutants. Eukaryot Cell 4 (2005) 1493-1502
23. Vediyappan G., and Chaffin W.L. Non-glucan attached proteins of Candida albicans biofilm formed on various surfaces. Mycopathologia 161 (2006) 3-10
24. Kruppa M., Krom B.P., Chauhan N., Bambach A.V., Cihlar R.L., and Calderone R.A. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot Cell 3 (2004) 1062-1065
25. Green C.B., Cheng G., Chandra J., Mukherjee P., Ghannoum M.A., and Hoyer L.L. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology 150 (2004) 267-275
26. Li F., and Palecek S.P. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell 2 (2003) 1266-1273
27. Ramage G., VandeWalle K., Lopez-Ribot J.L., and Wickes B.L. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214 (2002) 95-100
28. Nobile C.J., and Mitchell A.P. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15 (2005) 1150-1155. These investigators identify an important biofilm adhesion pathway in C. albicans.
29. Hawser S.P., and Douglas J.L. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62 (1994) 915-921
30. Honraet K., Goetghebeur E., and Nelis H.J. Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms. J Microbiol Methods 63 (2005) 287-295
31. Ramage G., and Lopez-Ribot J.L. Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med 118 (2005) 71-79. An excellent review of the in vitro methodology for qualitative and quantitative assessment of antifungal drug effect on biofilm growing C. albicans.
32. Nikawa H., Nishimura H., Hamada T., Yamashiro H., and Samaranayake L.P. Effects of modified pellicles on Candida biofilm formation on acrylic surfaces. Mycoses 42 (1999) 37-40
33. Ramage G., Tomsett K., Wickes B.L., Lopez-Ribot J.L., and Redding S.W. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 53-59
34. Lamfon H., Porter S.R., McCullough M., and Pratten J. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother 53 (2004) 383-385
35. Murillo L.A., Newport G., Lan C.Y., Habelitz S., Dungan J., and Agabian N.M. Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot Cell 4 (2005) 1562-1573. The authors examine the early transcriptional response of C. albicans to biofilm growth.
36. Garcia-Sanchez S., Aubert S., Iraqui I., Janbon G., Ghigo J.M., and d'Enfert C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 3 (2004) 536-545. The investigators use an in vitro perfused C. albicans biofilm model to explore the global transcriptional response to the biofilm growth-state.
37. Kumamoto C.A. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc Natl Acad Sci USA 102 (2005) 5576-5781
38. Arjomandi H, Barcelona SS, Gallocher SL, Vallejo M: Biofluid dynamics of the human circulatory system. Congress on Biofluid Dynamics of Human Systems, 2003 April 17; FIU Miami.
39. Samaranayake Y.H., and Samraanayake L.P. Experimental oral candidiasis in animal models. Clin Microbiol Rev 14 (2001) 398-429
40. Nemet B., and Zagar Z. Fibronectin concentrations in catheter sepsis. Clin Microbiol Infect 6 (2000) 121-124
41. Craig M.R., Poelstra K.A., Sherrell J.C., Kwon M.S., Belzile E.L., and Brown T.E. A novel total knee arthroplasty infection model in rabbits. J Orthop Res 23 (2005) 1100-1104. The authors detail development of an in vivo arthoplasty model in rabbits.
42. Xiong Y.Q., Willard J., Kadurugamuwa J.L., Yu J., Francis K.P., and Bayer A.S. Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat staphylococcus aureus endocarditis model. Antimicrob Agents Chemother 49 (2005) 380-387
43. Nikawa H., Nishimura H., Hamada T., Kumagai H., and Samaranayake L.P. Effects of dietary sugars and, saliva and serum on Candida bioflim formation on acrylic surfaces. Mycopathologia 139 (1997) 87-91
44. Nikawa H., Nishimura H., Makihira S., Hamada T., Sadamori S., and Samaranayake L.P. Effect of serum concentration on Candida biofilm formation on acrylic surfaces. Mycoses 43 (2000) 139-143
45. Jin Y., Samaranayake L.P., Samaranayake Y., and Yip H.K. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol 49 (2004) 789-798
46. Klotz S.A., Drutz D.J., and Zajic J.E. Factors governing adherence of Candida species to plastic surfaces. Infect Immun 50 (1985) 97-101
47. Etienne O., Gasnier C., Taddei C., Voegel J.C., Aunis D., Schaaf P., Metz-Boutigue M.H., Bolcato-Bellemin A.L., and Egles C. Antifungal coating by biofunctionalized polyelectrolyte multilayered films. Biomaterials 26 (2005) 6704-6712
48. Chandra J., Patel J.D., Li J., Zhou G., Mukherjee P.K., McCormick T.S., Anderson J.M., and Ghannoum M.A. Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 71 (2005) 8795-8801
49. Baillie G.S., and Douglas L.J. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob Agents Chemother 42 (1998) 2146-2149
50. Schinabeck M.K., Long L.A., Hossain M.A., Chandra J., Mukherjee P.K., Mohamed S., and Ghannoum M.A. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48 (2004) 1727-1732. This is the first in vivo catheter Candida biofilm model.
51. Kuhn D.M., George T., Chandra J., Mukherjee P.K., and Ghannoum M.A. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46 (2002) 1773-1780
52. Bachmann S.P., VandeWalle K., Ramage G., Patterson T.F., Wickes B.L., Graybill J.R., and Lopez-Ribot J.L. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46 (2002) 3591-3596
53. Andes D., Lepak A., Pitula A., Marchillo K., and Clark J. A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site. J Infect Dis 192 (2005) 893-900
54. Fradin C., and Hube B. Tissue infection and site-specific gene expression in Candida albicans. Adv Appl Microbiol 53 (2003) 271-290
55. Lorenz M.C., Bender J.A., and Fink G.R. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 3 (2004) 1076-1087
56. Kurosaka Y., Ishida Y., Yamaura E., Takase H., Otani T., and Kumon H. A nonsurgical rat model of foreign body-associated urinary tract infection with pseudomonas aeruginosa. Microbiol Immunol 45 (2001) 9-15